Pharmaceutical Technology and D&B Launch Business Marketplace - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology and D&B Launch Business Marketplace


Pharmaceutical Technology has joined with Dun & Bradstreet Credibility Corp. to launch the Pharmaceutical Technology and BioPharm International Marketplace, an online community developed to bring pharmaceutical buyers and suppliers together with Industry leading thought-leadership content from the publications, in-depth product information from suppliers, and real time social media features that allow members to integrate their company social media feeds into their profiles. Buyers will have the ability to rate and comment on products and services from suppliers.

Advanstar, publisher of pharmaceutical life science publications including Pharmaceutical Technology, is the first B2B publisher to embrace the online Credibility Review Business Marketplace platform developed by Dun & Bradstreet Credibility Corp.

“We are very excited about this opportunity. Given the high costs of developing eDirectories and continually upgrading and supporting these platforms across a wide array of publications, an alternative that leveraged lower upfront costs and scalability with speed to market was very attractive,” said Advanstar Executive Vice-President, Ron Wall.

According to eMarketer’s latest report, digital spending in pharmaceutical and healthcare marketing is forecasted to grow 57% to $2.48 billion by 2016. “Our vision is to create the largest and most dynamic communities of buyers and suppliers with Dun & Bradstreet Credibility Corp., so we can take full advantage of this spending growth,” said Wall.

According to Jeff Stibel, Chairman and CEO, Dun & Bradstreet Credibility Corp., “what we offer is a highly respected and branded platform with enhanced credibility data and information from our database, world class development expertise that will allow all of the Marketplace sites to benefit from ongoing upgrades and enhancements and a seamless integration of social media.”

The new Pharmaceutical Technology/BioPharm International Marketplace will concentrate on business information and news on companies in analytical/lab equipment, contract services, manufacturing equipment, packaging equipment/supplies, pharm/biopharm ingredients, and process control/IT.

Advanstar Life Sciences group will launch additional eDirectories supported by their other publications on the Dun & Bradstreet Credibility Review Marketplace in the coming months. Advanstar Communications Inc. is a leading marketing, media and events company providing integrated solutions for Fashion, Licensing, Life Sciences and Powersports industries. Advanstar serves business professionals and consumers in these industries with its portfolio of 141 events, 60 publications and directories, 233 electronic products, as well as educational and direct marketing products to facilitate commerce by connecting buyers and sellers across its vertical markets.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here